Safety and Efficacy of Doravirine (MK-1439) in Participants with Human Immunodeficiency Virus 1 (HIV-1) (MK-1439-018)

Trial Identifier: 1439-018
Sponsor: MSD
Start Date: December 2014
Primary Completion Date: September 2016
Study Completion Date: March 2023
Condition: Human Immunodeficiency Virus (HIV)

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
Results Plain Language Summary - EMEA French
Results Plain Language Summary - EMEA Romanian
Results Plain Language Summary - EMEA Afrikaans
Results Plain Language Summary - English
Results Plain Language Summary - EMEA German
Results Plain Language Summary – EMEA Spanish
Results Plain Language Summary - EMEA Xhosa
Results Plain Language Summary – EMEA_German
Results Plain Language Summary – EMEA Russian
Results Plain Language Summary – NA French Canadian
Results Plain Language Summary - LA Spanish

Trial Locations

No locations posted.